|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,260.30 INR | -2.23% |
|
-3.23% | -10.69% |
| Jun. 17 | Neuland Laboratories Says SEBI Issues Administrative Warning For Insider Trading Violation | RE |
| May. 23 | Neuland Laboratories Limited, Q4 2025 Earnings Call, May 15, 2025 |
Chart calendar Neuland Laboratories Limited
84f4c806.x0eSAhy88Pk4KjWQwiHy-BzldWqVtw7KDxyQANwvNXM.lCrwd3nXlIAPUlahgFS0ilrVNhD52UebbmalX4NcRV71c79RaP_IlnFcfA~02ba24d2fae42d9478ff6931dc7a75f8
Upcoming events on Neuland Laboratories Limited
Past events on Neuland Laboratories Limited
Past dividends on Neuland Laboratories Limited
| 2024-07-11 | Annual 14 INR |
| 2023-07-10 | Annual 10 INR |
| 2022-07-13 | Annual 5 INR |
| 2021-06-28 | Final Payment 3 INR |
| 2020-11-09 | Interim Payment 2 INR |
| 2020-02-17 | Interim Payment 2 INR |
| 2019-06-26 | Annual 1.2 INR |
| 2016-08-03 | Annual 2 INR |
| 2015-08-05 | Annual 1.5 INR |
| 2014-06-15 | Bonus Payment 1.5 INR |
| 2014-06-15 | Annual 1.5 INR |
| 2013-07-23 | Annual 1.2 INR |
| 2009-07-12 | Annual 3.5 INR |
| 2008-07-16 | Annual 2.5 INR |
| 2007-07-10 | Annual 2.5 INR |
| 2006-07-31 | Annual 2 INR |
| 2005-07-19 | Annual 1.2 INR |
| 2003-07-17 | Annual 1 INR |
| 2002-07-10 | Annual 1.8 INR |
| 2001-06-24 | Annual 1.5 INR |
Annual results
| Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 9 511 9 513 -0.02% | 11 912 10 295 15.71% | 15 586 15 825 -1.51% | 14 768 15 387 -4.02% | 18 797 | 23 515 |
|
EBITDA Million INR | Released Forecast Spread | 1 426 1 340 6.43% | 2 718 1 894 43.53% | 4 626 4 763 -2.87% | 3 233 3 855 -16.15% | 5 261 | 7 325 |
|
EBIT Million INR | Released Forecast Spread | 936 975 -3.97% | 0,00 0,00 - | 4 029 4 373 -7.86% | 2 577 3 373 -23.59% | 4 749 | 6 813 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 822 894 -8.04% | 2 157 1 231 75.26% | 4 014 4 144 -3.13% | 3 463 4 295 -19.36% | 4 723 | 6 633 |
|
Net income Million INR | Released Forecast Spread | 638 681 -6.21% | 1 635 911 79.49% | 3 001 3 108 -3.45% | 2 601 3 221 -19.25% | 3 517 | 4 941 |
|
EPS INR | Released Forecast Spread | 49,7 52,7 -5.62% | 127 78,8 61.74% | 234 241 -2.91% | 0,00 0,00 - | 273 | 383 |
| Announcement Date | 10/05/22 | 11/05/23 | 10/05/24 | 15/05/25 |
Quarterly results
| Fiscal Period | March | 2023 Q2 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 2 937 2 681 9.55% | 4 071 2 866 42.04% | 3 630 2 986 21.57% | 4 177 3 466 20.53% | 3 928 3 635 8.07% | 3 850 4 068 -5.36% | 4 396 3 824 14.95% | 4 328 | 3 699 | 4 029 | 4 199 | 4 293 | 5 113 | 5 423 |
|
EBITDA Million INR | Released Forecast Spread | 693 416 66.78% | 1 199 593 102.12% | 969 739 31.15% | 1 375 884 55.53% | 1 213 1 040 16.6% | 1 069 1 175 -9.01% | 1 234 972 26.91% | 1 502 | 867 | 1 262 | ||||
|
EBIT Million INR | Released Forecast Spread | 905 1 026 -11.84% | 1 071 892 20.01% | 901 | 897 | 767 | 997 | 955 | 1 342 | 1 396 | |||||
|
Net income Million INR | Released Forecast Spread | 385 215 78.88% | 845 332 154.65% | 619 426 45.26% | 892 548 62.86% | 814 658 23.69% | 676 744 -9.19% | 979 601 62.85% | 1 039 | 509 | 676 | ||||
| Announcement Date | 10/11/22 | 11/05/23 | 03/08/23 | 07/11/23 | 08/02/24 | 10/05/24 | 01/08/24 | - | - | - | - | - | - | - |
| 2025-07-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
| 2025-07-15 | GLAND PHARMA LIMITED: Q1 2026 Earnings Release (Projected) |
| 2025-07-16 06:45 am | JOHNSON & JOHNSON: Q2 2025 Earnings Release |
| 2025-07-16 | NOVARTIS AG: Q2 2025 Earnings Release |
| 2025-07-16 | CAMURUS AB: Q2 2025 Earnings Release |
| 2025-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2026 Earnings Release (Projected) |
| 2025-07-18 05:00 am | ORION OYJ: Q2 2025 Earnings Release |
| 2025-07-22 | LABORATORIOS FARMACEUTICOS ROVI, S.A.: Q2 2025 Earnings Release (Projected) |
| 2025-07-22 | TILRAY BRANDS, INC.: Q4 2025 Earnings Release (Projected) |
| 2025-07-22 | GENOMMA LAB INTERNACIONAL, S.A.B. DE C.V.: Q2 2025 Earnings Release (Projected) |
Past sector events for Neuland Laboratories Limited
| 2025-06-17 11:45 am | MEDINCELL S.A.: Q4 2025 Earnings Release |
| 2025-06-10 04:38 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2025 Sales and Revenue Release |
| 2025-06-09 04:48 am | YUNGSHIN GLOBAL HOLDING CORPORATION: May 2025 Sales and Revenue Release |
| 2025-06-08 08:01 pm | BORA PHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
| 2025-06-06 04:47 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: May 2025 Sales and Revenue Release |
| 2025-06-05 04:37 am | TTY BIOPHARM COMPANY LIMITED: May 2025 Sales and Revenue Release |
| 2025-06-03 04:35 am | ONENESS BIOTECH CO., LTD.: May 2025 Sales and Revenue Release |
| 2025-05-30 09:46 am | ASTRAZENECA PHARMA INDIA LIMITED: Q4 2025 Earnings Release |
| 2025-05-29 07:00 am | ROIVANT SCIENCES LTD.: Q4 2024 Earnings Release |
| 2025-05-29 04:31 am | ALKEM LABORATORIES LIMITED: Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NEULANDLAB Stock
- Calendar Neuland Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
